Resilience Biotechnologies Inc.
$93,848,000.00 CAD
- Program
- SIF Stream 2 - Growth
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- May 17, 2021 – January 1, 2054
- Reference
- ic:033-2021-2022-Q1-816022
Published purpose
This project will enhance Canada's biomanufacturing capabilities through expansion of aseptic fill-finish capacity, upgrades to critical manufacturing systems, and implementation of digital technologies at Resilience's Mississauga facility. The project’s work phase is scheduled to end on March 31, 2029.
In plain English AI-generated
This project funds Resilience Biotechnologies Inc. to expand its manufacturing capacity in Mississauga, Ontario, for vaccines, therapies, and fill/finish services to support Canada's response to COVID-19 and future pandemics.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.